68.15
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.74 | 1.1% | 68.15 | 67.61 | 69.56 | 69.13 | 67.41 | 18:01:09 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,323 | 614,794 | $ 68.80 | $ 42,295,569 | 782,001 | 26.56 - 69.56 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:30:00 | 36,411 | $ 68.15 | USD |
Biohaven Pharmaceutical Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.99B | 58.53M | 42.53M | $ - | $ - | -10.99 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 10.57M | $ - | 0.00% | -9.00 | 9.30% |
Biohaven Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 57.62 | 69.56 | 57.11 | 65.55 | 864,561 | 10.53 | 18.27% |
| 1 Month | 49.13 | 69.56 | 42.74 | 56.60 | 794,535 | 19.02 | 38.71% |
| 3 Months | 35.94 | 69.56 | 26.56 | 41.74 | 940,768 | 32.21 | 89.62% |
| 6 Months | 54.11 | 69.56 | 26.56 | 46.07 | 941,354 | 14.04 | 25.95% |
| 1 Year | 56.96 | 69.56 | 26.56 | 45.56 | 889,309 | 11.19 | 19.65% |
| 3 Years | 24.56 | 69.56 | 16.5001 | 41.42 | 557,958 | 43.59 | 177.48% |
| 5 Years | 20.00 | 69.56 | 16.5001 | 40.97 | 554,495 | 48.15 | 240.75% |
Biohaven Pharmaceutical Description
| Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others. |
